Drug-eluting stent platforms (DES)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Drug-eluting stent platforms (DES), covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Non-inferiority Clinical Trial to Compare the Safety and Performance of MeRes100 Sirolimus-eluting BioResorbable Vascular Scaffold System Versus Contemporary DES Platforms in Patients With de Novo Coronary Artery Lesions [NA]